A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

Cancer
Breast Cancer
Triple Negative Breast Cancer

Results
Download
Print

Study results

Atezo IMpassion131 LPS FINAL (PDF, 0.7 MB)

LPS MO39196 IMpassion131 Final Results December 2023 English (PDF, 1.5 MB)

LPS MO39196 IMpassion131 Final Results December 2023 German (PDF, 0.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

Study results

Atezo IMpassion131 LPS FINAL (PDF, 0.7 MB)

LPS MO39196 IMpassion131 Final Results December 2023 English (PDF, 1.5 MB)

LPS MO39196 IMpassion131 Final Results December 2023 German (PDF, 0.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

For the latest version of this information please go to www.forpatients.roche.com